Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service? Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
VTX-1463 | VTX-1463 | Phase 1 Clinical | Ventirx | Rhinitis, Allergic | Details |
CB-06 | CB 06036; CB-06 | Phase 1 Clinical | Shanghai Zhimeng Biopharma Inc | Hepatitis B | Details |
Bazlitoran | IMO-8400 | Idera | Details | ||
HRS-9950 | HRS-9950 | Phase 1 Clinical | Jiangsu Hengrui Medicine Co Ltd, Suzhou Suncadia Biopharmaceuticals Co Ltd, Shanghai Hengrui Pharmaceutical Co Ltd | Hepatitis B, Chronic | Details |
BDC-1001 | BDC-1001 | Phase 2 Clinical | Bolt Biotherapeutics Inc | Solid tumours | Details |
CV-8102 | CV-8102 | Phase 1 Clinical | Curevac Ag | Squamous Cell Carcinoma of Head and Neck; Skin Neoplasms; Carcinoma, Adenoid Cystic; Rabies; Carcinoma, Squamous Cell; Carcinoma, Hepatocellular; Melanoma | Details |
Motolimod | VTX-378; VTX-2337 | Phase 1 Clinical | Array Biopharma, Celgene Corp | Salivary Gland Neoplasms; Tongue Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Endometrioid; Melanoma; Carcinoma, Squamous Cell; Lymphoma; Paranasal Sinus Neoplasms; Laryngeal Neoplasms; Fallopian Tube Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Breast Neoplasms; Cystadenocarcinoma; Carcinoma, Verrucous; Pancreatic Neoplasms; Carcinoma, Ovarian Epithelial; Squamous Cell Carcinoma of Head and Neck; Cystadenocarcinoma, Serous; Cystadenocarcinoma, Mucinous; Carcinoma, Renal Cell; Lymphoma, B-Cell; Ovarian Neoplasms; Solid tumours; Brenner Tumor | Details |
Enpatoran | M-5049 | Phase 2 Clinical | Merck & Co Inc | Lupus Erythematosus, Cutaneous; Coronavirus Disease 2019 (COVID-19); Lupus Erythematosus, Systemic | Details |
TransCon-TLR-7/8-agonist | Phase 2 Clinical | Ascendis Pharma Oncology Division As | Solid tumours; Papillomavirus Infections; Neoplasm Metastasis | Details | |
Afimetoran | BMS-986256 | Phase 2 Clinical | Bristol-Myers Squibb Company | Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic | Details |
E-6742 | E-6742 | Phase 2 Clinical | Eisai Co Ltd | Lupus Erythematosus, Systemic | Details |
DN-1508052 | DN-1508052; DN1508052-01 | Phase 2 Clinical | Shanghai De Novo Pharmatech Co Ltd | Solid tumours; Neoplasms | Details |
BDB-018 | BDB-018 | Phase 1 Clinical | Seven And Eight Biopharmaceuticals Inc | Solid tumours | Details |
Selgantolimod | GS-9688 | Phase 2 Clinical | Gilead Inc | HIV Infections; Hepatitis B, Chronic; Hepatitis B | Details |
This web search service is supported by Google Inc.